NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries

Exclusion Criteria

• •1. Have active ocular infection.
• •2. Subjects with corneal perforation or impending corneal perforation.
• •3. Subjects with any other past or present ophthalmic disease or medical condition that, in the Investigator's opinion, may affect the safety of the subject or the outcome of the study.
• •4. Subjects with severe lid abnormalities or ocular conditions that contribute to the persistence of the epithelial defect.
• •5. Female subjects of childbearing potential who are pregnant, nursing, planning a pregnancy or not using an adequate and medically acceptable form of birth control.
• •6. Subjects who have participated in an interventional clinical trial within 30 days prior to Day 1.